U.S. Capital Markets Stock News

Wondering if American Electric Power Company at about US$136.91 is offering fair value or if you might be paying over the odds? This article breaks down what the current pricing could mean for you. The stock last closed at US$136.91, with returns of 1.6% over 7 days, 4.0% over 30 days, 18.2% year to date, 31.4% over 1 year, 66.4% over 3 years, and 86.7% over 5 years. This provides useful context before assessing any valuation metrics. Recent trading interest has been shaped by ongoing...

First Industrial Realty Trust expanded its board and appointed Frank E. Schmitz as an independent director. The move follows a recent activist investor campaign focused on board composition and governance. The appointment comes in a contested board setting, signaling a response to shareholder pressure. For investors watching NYSE:FR, this board change occurs at a time when the stock is trading at $62.14 and has returned 31.2% over the past year and 44.6% over the past five years. Those...

Gen Digital (NasdaqGS:GEN) has partnered with xAI to bring Grok large language models into its consumer platforms via the Gen AI Foundry. The company is launching VPN for Agents, presented as an industry first security tool tailored to autonomous AI agents. Gen Digital is also expanding Norton AI Agent Protection to address new cyber risks created by AI driven agents. Gen Digital, trading at $19.37, is adding these AI focused efforts on top of a share performance record that includes a...

Ultra Clean Holdings (NasdaqGS:UCTT) announced that Clarence Granger will step down as Chairman of the Board effective May 22, 2026. Tom Edman has been appointed to assume the Chairman role as the company adjusts its leadership at the board and executive levels. This change follows a period of executive transitions while the sector is influenced by increased AI related investment. Ultra Clean Holdings, trading at $74.61, has seen sharp share price moves recently, including a 10.1% decline...

Relay Therapeutics (RLAY) has drawn fresh attention after deciding to advance zovegalisib plus Pfizer’s atirmociclib into Phase 3 for PI3Ka-mutated, HR+/HER2- metastatic breast cancer, following early safety and response data in heavily pre-treated patients. See our latest analysis for Relay Therapeutics. The share price has been volatile around the latest zovegalisib update, with a 7 day share price return of negative 15.9%, following a 90 day share price return of 66.1% and a 1 year total...

In April 2026, Range Resources reported first-quarter 2026 results showing daily production of about 1,508,842 Mcf of natural gas, 108,193 barrels of NGLs, 8,239 barrels of oil and total revenue of US$1,034.17 million, with net income of US$341.63 million and diluted EPS of US$1.44 from continuing operations. Alongside these stronger operational and financial results, new Schedule 13G filings reveal that Vanguard entities have built passive stakes above 5% of Range Resources’ outstanding...

In late April 2026, Johnson & Johnson reported strong first‑quarter results with revenue of US$24.06 billion, raised its full‑year sales outlook to US$100.30–US$101.30 billion, increased its quarterly dividend to US$1.34 per share, and advanced key therapies including IMAAVY (nipocalimab) receiving FDA Priority Review in warm autoimmune hemolytic anemia and CAPLYTA (lumateperone) gaining an expanded label for preventing schizophrenia relapse. These moves highlight Johnson & Johnson’s effort...

If you are wondering whether New Jersey Resources at around US$56 is offering good value today, it helps to step back and look at what the recent price and fundamentals are really telling you. The stock has recently closed at US$56, with returns of 0.3% over 7 days, 1.8% over 30 days, 21.8% year to date, 17.6% over 1 year, 23.4% over 3 years, and 54.5% over 5 years. This gives plenty of data points to weigh up how the market currently views its prospects and risks. Recent coverage around New...

Context for Helios Technologies after recent performance Helios Technologies (HLIO) has drawn renewed investor interest after a recent period where the stock showed mixed moves, with a 2.3% decline over the past week and a 2.2% decline over the past month. See our latest analysis for Helios Technologies. Despite the recent soft patch in the share price, with a 30 day share price return of a 2.18% decline, momentum over a longer window still reflects a 22.17% year to date share price gain and...

National Fuel Gas (NFG) has recently drawn investor attention after its share price closed at $82.98, with recent returns showing mixed moves over the past week, month, and past 3 months. Investors may now reassess its fundamentals. See our latest analysis for National Fuel Gas. The recent 1 day share price return of negative 1.66% extends a short term pullback, with the 30 day share price return of negative 10.65% contrasting with a 5 year total shareholder return of 84.62%. This suggests...

Recent moves in BKV (BKV) stock come as investors weigh two catalysts: the upcoming May 7, 2026 earnings release, which is expected to show lower earnings on higher revenue, and fresh interest from a prominent hedge fund. See our latest analysis for BKV. At a share price of $31.32, BKV has seen a 14.98% 1 month share price return and a 68.39% 1 year total shareholder return, suggesting momentum has picked up as investors focus on the upcoming earnings update and hedge fund interest. If you...

Granite Construction (GVA) is back in focus after Q1 2026 results showed stronger than expected revenue, a higher full year revenue outlook to US$5.2b to US$5.4b, and record backlog supported by acquisitions. See our latest analysis for Granite Construction. The stronger Q1 2026 update appears to have fed into the share price, with Granite Construction’s 7 day share price return of 13.01% and 30 day return of 13.98% adding to a 1 year total shareholder return of 72.64%. This suggests momentum...

If you are wondering whether Callaway Golf at around US$15.16 is still reasonably priced after its recent run, the valuation story is the key place to focus. The stock has seen sharp moves, with a 29.4% return year to date and 121.3% over the last year, set against a 32.1% decline over three years and a 51.3% decline over five years. These swings have kept Callaway Golf on many watchlists, as investors weigh shorter term momentum of 9.7% over the last 30 days against a 1% decline over the...

In late April 2026, Match Group announced a US$100,000,000 minority investment in Sniffies, a real-time map-based cruising app for queer men, with an option to fully acquire the platform while keeping it founder-led and operationally independent. This move, alongside ongoing efforts to court LGBTQ users after acquiring Her, indicates Match Group is broadening its portfolio toward more niche, community-focused dating and social experiences. We’ll now explore how Match Group’s US$100,000,000...

In April 2026, Medpace Holdings reported first-quarter 2026 results showing sales of US$706.6 million and net income of US$123.87 million, with both basic and diluted earnings per share rising year over year, and issued full-year 2026 guidance for revenue of US$2.76–2.86 billion and GAAP net income of US$487.0–511.0 million alongside President Jesse Geiger’s planned retirement. An interesting detail for investors is that Medpace’s full-year 2026 outlook assumes a 19–20% tax rate and US$27.5...

Fidelis Insurance Holdings (NYSE:FIHL) has entered into a major share repurchase agreement that ends founding shareholder CVC Falcon Holdings Limited's ownership stake. The company has also approved amendments to its Bye Laws at its latest annual meeting, signaling changes to its governance framework. These decisions mark a meaningful shift in ownership and corporate rules that is relevant for existing and prospective shareholders. Fidelis Insurance Holdings, a specialty insurance and...

If you are wondering whether Incyte's current share price still offers value or has already priced in recent enthusiasm, the next sections will walk through what the numbers actually say. Over the past year the stock has returned 55.0%, with shorter term moves of 2.4% over 7 days, 2.8% over 30 days and a year to date return of a 4.4% decline, which can change how the market views both its growth potential and its risks. Recent coverage has focused on Incyte's position in biotech and the...

Huntsman (HUN) opened 2026 with Q1 revenue of US$1.4 billion and a basic EPS loss of US$0.30, while the trailing twelve months show revenue of US$5.7 billion and a basic EPS loss of US$1.87. Over recent quarters, revenue has ranged between US$1.4 billion and US$1.5 billion, with quarterly basic EPS losses stretching from roughly US$0.02 to US$0.92. Investors are therefore looking at a business that is still working through margin pressure rather than expanding profitability. See our full...

Wondering if Teradyne at US$345.42 is priced for perfection or still offers value? This article breaks down what the current market price might be implying. The stock has seen sharp moves, with a 17.4% decline over the last 7 days, an 11.6% gain over 30 days, and returns of 66.4% year to date and 356.9% over the past year. Recent coverage of Teradyne has focused on its role in semiconductors and automation, and how investor interest in these themes has lined up with the share price moves...

In late April 2026, Teva Pharmaceutical Industries reported first‑quarter 2026 results showing higher sales of US$3,982 million and net income of US$369 million, alongside much smaller impairment charges than a year earlier. Beyond the headline numbers, growth in innovative products such as UZEDY and the planned acquisition of Emalex Biosciences signal a deeper shift toward higher‑margin neuroscience and specialty medicines. Now we will examine how Teva’s stronger first‑quarter profitability...

Nutex Health (NUTX) is back on investors’ radar after Q1 2026 results showed net income more than doubling year over year, stronger EPS, and continued hospital expansion plans supported by its existing arbitration driven model. See our latest analysis for Nutex Health. That earnings surprise and expansion pipeline have coincided with a sharp rebound in the shares, with a 1 day share price return of 17.1%, 7 day share price return of 28.9% and 30 day share price return of 41.8%. The 1 year...

Wondering if Alphabet's share price actually lines up with its underlying value, or if enthusiasm has run ahead of the numbers. Alphabet recently closed at US$385.69, with reported returns of 12.0% over 7 days, 29.7% over 30 days, 22.4% year to date and 135.9% over 1 year. Recent headlines have focused on Alphabet's role in artificial intelligence and ongoing product updates across search, cloud services and advertising. These stories help explain why investors are paying close attention to...

MaxLinear (NasdaqGS:MXL) introduced its Washington 200G per lane optical transimpedance amplifier for 1.6T AI data center interconnects. Samples of the new TIA are currently available to customers, with mass production targeted for the second half of 2026. The launch comes as the company reports upgraded sales targets and momentum in its optical business. For investors tracking AI infrastructure, this move places MaxLinear closer to the core of next generation data center build outs. The...

Kearny Financial Corp. ( NASDAQ:KRNY ) stock is about to trade ex-dividend in 3 days. Typically, the ex-dividend date...